Johnson & Johnson is not having a good week. First the FDA added a warning to the label for the company’s COVID-19 vaccine. The warning states that there may be a risk of contracting Guillain-Barre syndrome.
The US Food and Drug Administration updated the label on Johnson & Johnson’s coronavirus vaccine Monday to warn of the possible increased risk of a rare neurological complication known as Guillain-Barré syndrome. While the FDA said it had not established the vaccine could cause the syndrome, it noted an increase in reports of the sometimes paralyzing condition. “Today, the FDA is announcing revisions to the vaccine recipient and vaccination provider fact sheets for the Johnson & Johnson (Janssen) COVID-19 Vaccine to include information pertaining to an observed increased risk of Guillain-Barré Syndrome (GBS) following vaccination,” it said in a statement sent to CNN.CNN
Second, J&J has decided to recall Aveeno & Neutrogena spray sunscreens after detecting levels of benzene in the products.
Johnson & Johnson is recalling most of its Neutrogena and Aveeno spray sunscreens from U.S. stores after detecting benzene, a potentially cancer-causing chemical, in some samples.
J&J said Wednesday consumers should stop using and discard five of its six Neutrogena and Aveeno spray sunscreens. The company said it is also notifying distributors and retailers to stop selling the products, and arranging for the return of the products.
A company spokesman said the effort would include removing products from shelves.Wall Street Journal